Juvenile Dermatomyositis Latest Advances

Find the Latest Research About Juvenile Dermatomyositis

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1506 publications

Severe Juvenile Dermatomyositis With Peripheral Nervous System Involvement: A Case Report.

Severe Juvenile Dermatomyositis With Peripheral Nervous System Involvement: A Case Report.

Journal: Cureus
Published: February 16, 2026

Hospitalized Versus Outpatient Benign Acute Childhood Myositis: A 10-Year Single-Center Experience.

Hospitalized Versus Outpatient Benign Acute Childhood Myositis: A 10-Year Single-Center Experience.

Journal: Medicina (Kaunas, Lithuania)
Published: February 07, 2026

Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis.

Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis.

Journal: Rheumatology advances in practice
Published: January 19, 2026

Use of the EOS 2D/3D Imaging System for the Evaluation of Calcinosis in Juvenile Dermatomyositis: A Retrospective Case Series.

Use of the EOS 2D/3D Imaging System for the Evaluation of Calcinosis in Juvenile Dermatomyositis: A Retrospective Case Series.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: December 23, 2025

Towards New Strategies: Case Report and Review of the Literature-Effective Use of JAK Inhibitor Baricitinib in a 4-Year-Old Boy with Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis.

Towards New Strategies: Case Report and Review of the Literature-Effective Use of JAK Inhibitor Baricitinib in a 4-Year-Old Boy with Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis.

Journal: Journal of clinical medicine
Published: December 13, 2025

Clinical use of intravenous immunoglobulin in juvenile dermatomyositis: indications, treatment course, and clinical outcomes.

Clinical use of intravenous immunoglobulin in juvenile dermatomyositis: indications, treatment course, and clinical outcomes.

Journal: Expert opinion on biological therapy
Published: December 11, 2025

Juvenile dermatomyositis as a rare paraneoplastic manifestation of nasopharyngeal carcinoma.

Juvenile dermatomyositis as a rare paraneoplastic manifestation of nasopharyngeal carcinoma.

Journal: Rheumatology (Oxford, England)
Published: November 28, 2025

Presence of Multiple Muscle Specific Autoantibodies (MSAs) in a Young Child with Juvenile Dermatomyositis.

Presence of Multiple Muscle Specific Autoantibodies (MSAs) in a Young Child with Juvenile Dermatomyositis.

Journal: Indian journal of pediatrics
Published: November 28, 2025

Correction: A retrospective natural history study in adult and juvenile patients with incident dermatomyositis and polymyositis using real world data.

Correction: A retrospective natural history study in adult and juvenile patients with incident dermatomyositis and polymyositis using real world data.

Journal: Clinical rheumatology
Published: November 20, 2025

Intermittent Glucocorticoid Pulse Combined With Mycophenolate Mofetil in Juvenile Dermatomyositis.

Intermittent Glucocorticoid Pulse Combined With Mycophenolate Mofetil in Juvenile Dermatomyositis.

Journal: JAMA dermatology
Published: November 19, 2025

A case of inclusion body myositis with childhood onset

A case of inclusion body myositis with childhood onset

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: November 13, 2025

Clinical characteristics of juvenile dermatomyositis in anti-nuclear matrix protein 2 antibody-positive patients and risk factors for severity: a national multicenter retrospective study

Clinical characteristics of juvenile dermatomyositis in anti-nuclear matrix protein 2 antibody-positive patients and risk factors for severity: a national multicenter retrospective study

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: November 13, 2025
Showing 1-12 of 1,506

Last Updated: 04/28/2026